LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT07361679
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Alexandra Hospital, Athens, Greece
- Registry
-
NCT07361679
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Greece
- Registry status
- Completed
Technical summary
Registry record NCT07361679. Randomized; no masking; primary purpose prevention. Start 2023-01-18 (actual); primary completion 2026-11-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention
- Acronym
- preGO
- Condition
- Preeclampsia Severe
- Condition
- Toxemia Of Pregnancy
- Condition
- Preeclampsia
- Condition
- Pregnancy Complications
- Condition
- Hypertension, Pregnancy-Induced
- Condition
- Gestational Hypertension
- Intervention (Drug)
- Aspirin
- Intervention (Drug)
- Tinzaparin
- Lead sponsor
- Alexandra Hospital, Athens, Greece
Record details
- Record id
cardio:ct-nct07361679- Content hash
aab98891a95ea0967714e197154b564a613ef135fccd9e47f82792feb446aa52